With its Poolbeg Pharma merger plans having bitten the dust and key assets sold off to Gilead, Hookipa Pharma has decided ...

Biotech company CRISPR Therapeutics has a market cap of around $5 billion, but it has the potential to be much more valuable ...

Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights ...

However, revenue from operations jumped 11.04% to Rs 543.72 crore in the first quarter of FY26 as against Rs 489.65 crore posted in the corresponding quarter last year.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts.

Ascentage Pharma Group International (NASDAQ:AAPG) is one of the best performing mid cap stocks so far in 2025.

Thanks to advanced biotechnology, bourbon stillage is now a source for “multifunctional alternative proteins.” ...

The pace of quarterly reports is stiffening and in the main, like a lamington, the news is easy to digest for ASX biotech investors.

Jackson Tai ’72, a leader in cross-border finance and risk governance, and his wife, Kay, have made a transformative $5 million gift to Rensselaer Polytechnic Institute (RPI), ...

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Cellugy's EcoFLEXY is a bio-based answer to the petroleum-based ingredients commonly used in skincare products to create ...

Cabometyx has since earned numerous label expansions, and it continues to help drive solid top- and bottom-line growth for Exelixis. In the first quarter, the company's revenue jumped by 30.6% year ...